ARTICLE | Clinical News
MVA-BN RSV: Completed Ph II enrollment
December 20, 2016 12:48 AM UTC
Bavarian Nordic completed enrollment of about 400 healthy volunteers ages ≥55 in a single-blind, placebo-controlled, U.S. Phase II trial evaluating 2 dose levels of MVA-BN RSV given once or twice 4 we...
BCIQ Company Profiles
BCIQ Target Profiles